Main > RHEUMATOLOGY > USA. G. RA>Treat.>JAK Inhibitor Tab

---

USA. G. RA>Treat.>JAK Inhibitor Tab's subsections
(*) EU Approval Date: 2020. 09.25
(*) JP Approval Date: 2020. 09.25
(*) JP Launch Date: 2020. 11.18
Company
Company Licensee JP
Generic Name: Filgotinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 12.28
RTM
RTM Web-Site (EU)

USA. G. RA>Treat.>JAK Inhibitor Tab's products
This section has no products